ICAD, Inc. Showcases Technology for Cancer 'Discovery to Recovery' Including Profound AI Platform and Xoft System At Arab Health 2020 in Dubai
January 27, 2020 at 06:30 pm IST
Share
iCAD, Inc. announced it will showcase its advancements in cancer detection and therapy, including ProFound AI and the Xoft Axxent Electronic Brachytherapy (eBx) System, in the iCAD exhibition booth (# S1.C71) at Arab Health 2020 in Dubai from January 27-30. iCAD’s Breast Health Solutions suite includes ProFound AI for Digital Breast Tomosynthesis (DBT), as well as software solutions for 2D mammography and breast density. ProFound AI is a high-performing workflow solution featuring the latest in deep-learning artificial intelligence capabilities. In December 2018, ProFound AI for DBT became the first artificial intelligence software for DBT to be cleared by the U.S. Food and Drug Administration; it was also CE marked and Health Canada licensed that same year. ProFound AI for 2D Mammography was CE marked in July 2019. Intended to be used by radiologists reviewing mammography or DBT images, ProFound AI rapidly and accurately analyzes each individual image, or slice, and identifies potentially malignant lesions. Trained with one of the available image datasets, it provides radiologists with crucial information, such as Certainty of Finding lesion and Case Scores, which assists in clinical decision-making and prioritizing caseloads. The technology also allows for continuously improved performance via ongoing product updates. Positive clinical data from a large reader study involving ProFound AI for DBT were recently published in Radiology: Artificial Intelligence. According to study findings, ProFound AI for DBT improved radiologist sensitivity by 8%, reduced unnecessary patient recall rates by 7.2%, and slashed reading time for radiologists by 52.7%. Additionally, ProFound AI for DBT cut reading time by up to 57.4% for radiologists reading cases with dense breasts.
iCAD, Inc. provides artificial intelligence-powered cancer detection. Its ProFound Breast Health Suite enables medical providers and professionals to accurately and reliably identify where cancer may be hiding. Its Cancer Detection segment solutions include advanced artificial intelligence and image analysis workflow solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing the prevalent cancers earlier, a range of upgradeable computer-aided detection systems and workflow solutions for digital breast tomosynthesis, full-field digital mammography, magnetic resonance imaging and computed tomography. ProFound Suite offers 360-degree solutions for cancer detection, density assessment, and personalized risk evaluation, all based on a 2D or 3D mammogramâs collection of images. ProFound Density Assessment standardizes and simplifies breast density reporting, algorithmically examining a womanâs breast anatomy from the mammogram image.